Clinical Trials on Human Immunodeficiency Virus Type 1 in Luxembourg
Total 16 results
-
Centre Hospitalier du LuxembourgUniversity of Cambridge; Luxembourg Institute of HealthCompletedType1 Diabetes MellitusLuxembourg
-
Centre Hospitalier du LuxembourgUniversity of CambridgeCompletedType 1 Diabetes MellitusLuxembourg
-
Luxembourg Institute of HealthCompletedDiabetes Distress | type1diabetesLuxembourg
-
Centre Hospitalier du LuxembourgCompletedDiabetes Mellitus, Type 1Luxembourg
-
University of CambridgeMedical University of Graz; Medical University of Vienna; The Leeds Teaching... and other collaboratorsCompletedType 1 Diabetes MellitusUnited Kingdom, Austria, Germany, Luxembourg
-
University of CambridgeMedical University of Graz; Medical University of Vienna; The Leeds Teaching... and other collaboratorsCompletedType 1 Diabetes MellitusUnited Kingdom, Austria, Germany, Luxembourg
-
GlaxoSmithKlineCompletedHIV Infection | Infection, Human Immunodeficiency VirusUnited States, Belgium, France, Germany, Spain, Canada, Italy, Portugal, Romania, Austria, Switzerland, Poland, Latvia, Luxembourg
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1France, Belgium, Luxembourg
-
University of CambridgeJuvenile Diabetes Research Foundation; The Leona M. and Harry B. Helmsley Charitable... and other collaboratorsUnknownType 1 Diabetes MellitusAustria, Italy, Finland, Denmark, Germany, Belgium, United Kingdom, France, Luxembourg, Norway, Poland, Slovenia, Sweden
-
Medtronic DiabetesCompletedDiabetes Mellitus, Type 1Netherlands, Slovenia, Denmark, Austria, Italy, Luxembourg, Spain
-
Janssen-Cilag International NVCompletedHepatitis C, ChronicUnited Kingdom, Belgium, Germany, Portugal, Russian Federation, Hungary, Ireland, Luxembourg
-
University of HelsinkiEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedDiabetes Mellitus, Type 1Spain, Luxembourg, Australia, Switzerland, Canada, Germany, Hungary, United States, Czechia, Estonia, Finland, Italy, Netherlands, Poland, Sweden
-
University of MinnesotaNational Health and Medical Research Council, Australia; Bristol-Myers Squibb; National Institutes of Health Clinical Center (CC) and other collaboratorsCompletedHIV InfectionSpain, United States, United Kingdom, Ireland, Australia, Argentina, Denmark, Sweden, Israel, Switzerland, Germany, Brazil, Norway, Chile, Thailand, Peru, Portugal, Greece, Luxembourg, Uganda, Austria, Belgium, Czechia, Estonia, Finland, ... and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United Kingdom, Denmark, Sweden, Netherlands, Belgium, Finland, France, Australia, Ireland, Norway
-
Janssen-Cilag International NVNo longer availableHepatitis CAustralia, Belgium, Germany, Spain, Switzerland, Romania, Serbia, Greece, New Zealand, Brazil, Russian Federation, Austria, Hungary, Czech Republic, Luxembourg
-
Rigshospitalet, DenmarkUniversity College, LondonEnrolling by invitationEnd Stage Liver Disease | Cardiovascular Diseases | Fractures, Bone | Diabetes Mellitus | Renal Insufficiency | Hepatitis B | Hepatitis C | Kidney Failure, Chronic | Proteinuria | HIV | Coinfection | Acidosis, Lactic | AIDSSpain, Switzerland, Germany, United Kingdom, Austria, Sweden, Finland, Israel, Denmark, France, Italy, Iceland, Belgium, Slovakia, Norway, Lithuania, Portugal, Poland, Croatia, Czechia, Greece, Hungary, Luxembourg, Argentina, Belarus, Bosnia... and more